OGNHealthcare
Organon & Co. (OGN) Insider Trading
In the last 90 days, 1 Organon & Co. (OGN) insider reported no open-market purchases and 1 sale totaling $200,307. Source: SEC Form 4 filings.
SEC-reported filing activity is provided for research purposes and is not investment advice.
- 90-day C-suite buyers
- 0
- 90-day purchase value
- $0.00
- Corporate buyers
- 0
- Latest transaction
- Aug 5, 2026
Executive filings
Open-market transaction history
Purchase and sale summaries are ordered by the latest reported transaction date.
Common questions
OGN insider trading FAQ
- Are OGN insiders buying or selling?
- Over the last 90 days, OGN insiders were net sellers, reporting $0.00 of open-market purchases and $200,307 of sales.
- When was the last OGN insider purchase?
- No open-market insider purchase of Organon & Co. stock was reported in the last 90 days.
- Where does OGN insider trading data come from?
- Watch Insiders reads the SEC Form 4 filings that Organon & Co. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.
Healthcare
Related tickers with recent insider filings
- UTHR insider tradingUnited Therapeutics Corp69 filings
- TWST insider tradingTwist Bioscience Corp37 filings
- TEM insider tradingTempus AI Inc24 filings
- NTRA insider tradingNatera Inc22 filings
- CSTL insider tradingCastle Biosciences Inc21 filings
- CORT insider tradingCorcept Therapeutics Inc20 filings
- MEDP insider tradingMedpace Holdings Inc19 filings
- RVMD insider tradingRevolution Medicines Inc19 filings
